Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

UPDATE: Traws Pharma Q1 Adj. EPS $(1.58) Beats $(8.04) Estimate, Sales $57.00K Miss $60.00K Estimate

Author: Benzinga Newsdesk | May 15, 2025 07:31am
Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(8.04) by 80.35 percent. This is a 73.31 percent increase over losses of $(5.92) per share from the same period last year. The company reported quarterly sales of $57.00 thousand which missed the analyst consensus estimate of $60.00 thousand by 5.00 percent. This is a 1.79 percent increase over sales of $56.00 thousand the same period last year.

Posted In: TRAW


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist